Risk Factors Associated with Long COVID Syndrome: A Retrospective Study.
COVID-19
Medicine
SARS-CoV-2
Viruses
Journal
Iranian journal of medical sciences
ISSN: 1735-3688
Titre abrégé: Iran J Med Sci
Pays: Iran
ID NLM: 8104374
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
21
07
2021
revised:
30
08
2021
accepted:
29
09
2021
entrez:
29
11
2021
pubmed:
30
11
2021
medline:
24
12
2021
Statut:
ppublish
Résumé
Recently, people have recognized the post-acute phase symptoms of the COVID-19. We investigated the long-term symptoms associated with COVID-19, (Long COVID Syndrome), and the risk factors associated with it. This was a retrospective observational study. All the consecutive adult patients referred to the healthcare facilities anywhere in Fars province from 19 February 2020 until 20 November 2020 were included. All the patients had a confirmed COVID-19 diagnosis. In a phone call to the patients, at least three months after their discharge from the hospital, we obtained their current information. The IBM SPSS Statistics (version 25.0) was used. Pearson Chi square, Fisher's exact test, In total, 4,681 patients were studied, 2915 of whom (62.3%) reported symptoms. The most common symptoms of long COVID syndrome were fatigue, exercise intolerance, walking intolerance, muscle pain, and shortness of breath. Women were more likely to experience long-term COVID syndrome than men (Odds Ratio: 1,268; 95% Confidence Interval: 1,122-1,432; P=0.0001), which was significant. Presentation with respiratory problems at the onset of illness was also significantly associated with long COVID syndrome (Odds Ratio: 1.425; 95% Confidence Interval: 1.177-1.724; P=0.0001). A shorter length of hospital stay was inversely associated with long COVID syndrome (Odds Ratio: 0.953; 95% Confidence Interval: 0.941-0.965; P=0.0001). Long COVID syndrome is a frequent and disabling condition and has significant associations with sex (female), respiratory symptoms at the onset, and the severity of the illness.
Sections du résumé
Background
Recently, people have recognized the post-acute phase symptoms of the COVID-19. We investigated the long-term symptoms associated with COVID-19, (Long COVID Syndrome), and the risk factors associated with it.
Methods
This was a retrospective observational study. All the consecutive adult patients referred to the healthcare facilities anywhere in Fars province from 19 February 2020 until 20 November 2020 were included. All the patients had a confirmed COVID-19 diagnosis. In a phone call to the patients, at least three months after their discharge from the hospital, we obtained their current information. The IBM SPSS Statistics (version 25.0) was used. Pearson Chi square, Fisher's exact test,
Results
In total, 4,681 patients were studied, 2915 of whom (62.3%) reported symptoms. The most common symptoms of long COVID syndrome were fatigue, exercise intolerance, walking intolerance, muscle pain, and shortness of breath. Women were more likely to experience long-term COVID syndrome than men (Odds Ratio: 1,268; 95% Confidence Interval: 1,122-1,432; P=0.0001), which was significant. Presentation with respiratory problems at the onset of illness was also significantly associated with long COVID syndrome (Odds Ratio: 1.425; 95% Confidence Interval: 1.177-1.724; P=0.0001). A shorter length of hospital stay was inversely associated with long COVID syndrome (Odds Ratio: 0.953; 95% Confidence Interval: 0.941-0.965; P=0.0001).
Conclusion
Long COVID syndrome is a frequent and disabling condition and has significant associations with sex (female), respiratory symptoms at the onset, and the severity of the illness.
Identifiants
pubmed: 34840383
doi: 10.30476/ijms.2021.92080.2326
pii: IJMS-46-6
pmc: PMC8611223
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
428-436Informations de copyright
Copyright: © Iranian Journal of Medical Sciences.
Références
Clin Microbiol Infect. 2021 Oct;27(10):1507-1513
pubmed: 34111579
J Thromb Haemost. 2021 Oct;19(10):2546-2553
pubmed: 34375505
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Lung. 2021 Apr;199(2):113-119
pubmed: 33569660
Future Microbiol. 2020 Sep;15:1287-1305
pubmed: 32851877
Thorax. 2021 Apr;76(4):396-398
pubmed: 33172844
EClinicalMedicine. 2020 Aug;25:100463
pubmed: 32838236
Clin Med (Lond). 2020 Jul;20(4):359-365
pubmed: 32518105
J Neurovirol. 2021 Feb;27(1):154-159
pubmed: 33528827
EClinicalMedicine. 2021 May 24;36:100899
pubmed: 34036253
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2823-2833
pubmed: 33501506
Clin Infect Dis. 2021 Aug 2;73(3):e826-e829
pubmed: 33624010
Thorax. 2021 Apr;76(4):399-401
pubmed: 33273026
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
Med Clin (Barc). 2021 May 7;156(9):449-458
pubmed: 33478809
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Clin Auton Res. 2020 Oct;30(5):449-451
pubmed: 32880754
Eur J Phys Rehabil Med. 2020 Oct;56(5):633-641
pubmed: 32667150
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
Pain Rep. 2021 Feb 16;6(1):e887
pubmed: 33615088
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):145-146
pubmed: 33341598
J Neurol Sci. 2020 Dec 15;419:117179
pubmed: 33070003
Clin Microbiol Infect. 2020 Dec;26(12):1690.e1-1690.e4
pubmed: 32898715
Int J Obes (Lond). 2021 Jun;45(6):1163-1169
pubmed: 33727631